[NVIC] Mandated Genital Herpes Vaccine?

[Guest guest]

The VICP should never have been developed even though everyone who was part

of it meant well at the time.

This has only led to the situation where drug companies can get away with

anything.

Sheri

E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER

Vienna, Virginia http://www.nvic.org

* * * * * * * * * * * * * * * * * * * * * * *

UNITED WAY/COMBINED FEDERAL CAMPAIGN

#9119

* * * * * * * * * * * * * * * * * * * * * * *

" Protecting the health and informed consent rights of children since 1982. "

============================================================================

==============

BL Fisher Note:

Drug companies want every vaccine they produce to be recommended by the CDC

for " universal use. " Once the CDC puts a " universal use " label on a vaccine,

the vaccine is added to the Vaccine Injury Compensation Program (VICP) and

the drug company is protected from liability for vaccine injuries and

deaths. At the same time, the vaccine is purchased in bulk by the government

under the Vaccines For Children (VFC) program supplying free vaccine to

public health clinics. At the same time, the drug company lobbyists join

with physician organizations and state public health officials to lobby for

adding the vaccine to state vaccine laws while the CDC gives grants to

states to achieve high vaccination rates using it. If they can mandate

hepatitis B vaccine for children for an adult disease primarily prevalent

among injecting drug users and persons with multiple sexual partners, they

can mandate every other vaccine that targets sexually transmitted diseases,

including genital herpes.

http://www.journals.uchicago.edu/CID/journal/issues/v40n9/35035/brief/35035.

abstract.html

Clinical Infectious Diseases 2005;40:1271-1281

1058-4838/2005/4009-0010$15.00

Safety and Immunogenicity of Glycoprotein DAdjuvant Genital Herpes Vaccine

I. Bernstein,1 Fred Y. Aoki,4 K. Tyring,2 Lawrence R.

Stanberry,3 Claude St.-Pierre,5 D. Shafran,6 Geert Leroux-Roels,7

Koen Van Herck,8 Anne Bollaerts,9 and Dubin,9 for The GlaxoKline

Herpes Vaccine Study Groupa

1Cincinnati Children's Hospital Medical Center and the University of

Cincinnati, Ohio; 2University of Texas Health Science Center, Houston, and

3University of Texas Medical Branch, Galveston, Texas; 4University of

Manitoba, Winnipeg, 5Novabyss, Sherbrooke, Quebec, and 6University of

Alberta, Edmonton, Canada; and 7Rijks Universiteit Gent, Ghent,

8Universiteit Antwerpen, Antwerp, and 9GlaxoKline Biologicals,

Rixensart, Belgium

Background. Two previous trials have suggested that a herpes

simplex virus (HSV) type 2 glycoprotein D (gD) vaccine combined with the

adjuvants alum and 3-O-deacylated-monophosphoryl lipid A (MPL) is well

tolerated and provides protection against genital herpes disease in women

with no preexisting HSV antibody.

Methods. The safety and immunogenicity of this vaccine were

evaluated in a large, multicenter, double-blind, randomized,

placebo-controlled trial. The effects of sex and preexisting HSV immunity

were sought.

Results. When solicited symptoms that continued after the initial 4

days of observation were excluded, the incidence of unsolicited symptoms

occurring during the 7 months after vaccination (the primary analysis

period) was 22.1% in vaccine recipients and 21.9% in placebo recipients.

Significant increases in the number of local and systemic symptoms were

found in vaccine recipients within 4 days after vaccination. However, most

symptoms were mild to moderate in severity and were short lived. Women

reported symptoms more frequently than did men, but preexisting immunity had

little effect. The vaccine induced higher titers of HSV gD antibody on

enzyme-linked immunosorbent assays than did natural infection with HSV.

Conclusion. The vaccine was generally safe, well tolerated, and

immunogenic.

=============================================

News@... is a free service of the National Vaccine Information

Center and is supported through membership donations. Learn more about

vaccines, diseases and how to protect your informed

consent rights http://www.nvic.org

Become a member and support NVIC's work

https://www.909shot.com/Making%20Cash%20Donations.htm

To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm

NVIC is funded through individual membership donations and does not receive

government funding. Barbara Loe Fisher, President and Co-founder.

NOTE: This is not an interactive e-mail list. Please do not respond to

messages.

--------------------------------------------------------

Sheri Nakken, R.N., MA, Classical Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales UK

$$ Donations to help in the work - accepted by Paypal account

vaccineinfo@... voicemail US 530-740-0561

(go to http://www.paypal.com) or by mail

Vaccines - http://www.nccn.net/~wwithin/vaccine.htm

Vaccine Dangers On-Line course - http://www.nccn.net/~wwithin/vaccineclass.htm

Homeopathy On-Line course - http://www.nccn.net/~wwithin/homeo.htm

ANY INFO OBTAINED HERE NOT TO BE CONSTRUED AS MEDICAL

OR LEGAL ADVICE. THE DECISION TO VACCINATE IS YOURS AND YOURS ALONE.

******

" Just look at us. Everything is backwards; everything is upside down.

Doctors destroy health, lawyers destroy justice, universities destroy

knowledge, governments destroy freedom, the major media destroy information

and religions destroy spirituality " .... Ellner